First-Generation Antipsychotics: Uses, Movement Effects and Safe Review

Examples include haloperidol, chlorpromazine, fluphenazine and perphenazine. These medicines alter brain signaling and can treat psychotic symptoms. The word antipsychotic does not reveal every reason a medicine might be prescribed: chlorpromazine and perphenazine also have certain nonpsychiatric uses, such as treatment of severe nausea and vomiting. The relevant indication should be stated in the prescription record. [1] [2] [3]

A class name is not a dose guide. A smaller number of milligrams does not mean a weaker clinical effect or a safer medicine. Do not compare tablet strengths across different products or substitute one for another using an online equivalence table. A change requires a prescriber who can assess the treatment goal, adverse effects and current regimen.

Conventional antipsychotics are used in treatment of schizophrenia and other psychotic disorders. Some also have roles in managing mania, depending on the medicine and local authorization. A medicine introduced during an acute episode may subsequently be reviewed for longer-term treatment. The plan should explain whether the immediate target is psychosis, a manic episode or another specifically assessed problem. [1] [4]

Ask how progress will be recognized. Reduced distress, clearer thinking and improved everyday functioning are different from simply being sleepy or less active. Write down what matters to you: being able to concentrate, take part in family life or manage ordinary responsibilities. A review should give space to both the intended benefit and anything that makes the treatment difficult to live with.

The choice of an antipsychotic should consider previous response, likely adverse effects, physical health and the person’s preferences. NICE does not recommend choosing solely from the age of the medicine. It encourages an explicit treatment trial and discussion of metabolic, movement, cardiovascular and hormonal effects. A well-tolerated existing prescription should not be replaced merely because another medicine is described as newer. [5]

Equally, familiarity is not a reason to ignore a problem. A treatment used for years may need review when health, age, other prescriptions or daily circumstances change. Explain what has become difficult and when it changed. The question is not whether older or newer medicines are universally better, but whether this particular plan still fits.

Products differ in available forms and administration. Fluphenazine, for example, has oral tablets and liquid preparations whose measurement instructions matter. Some antipsychotics also have long-acting injectable formulations; these should be distinguished from injections used for immediate symptom management. A medicine list should identify the formulation and schedule rather than recording only the active ingredient. [2] [5]

If you receive an injection, ask who books the next appointment, what happens if it is missed and whether any oral treatment is intended to continue. Do not add tablets to compensate for a delayed injection yourself. When using a liquid, ask the pharmacist to demonstrate the measuring device; a household spoon or a guessed dilution is not an adequate substitute for product instructions.

Antipsychotic-related movement effects can include stiffness, tremor, slowed movement, an uncomfortable need to move and involuntary movements. Akathisia may feel like intense internal restlessness and can be confused with anxiety or worsening agitation. Tardive dyskinesia may involve repeated movements of the mouth, tongue or other body parts. Different problems require different clinical assessment; the same extra medicine will not necessarily be appropriate for all of them. [5]

Describe what you notice rather than trying to assign the diagnosis yourself. Can you sit through a meal? Is there a new shuffling walk? Has someone noticed repeated tongue or jaw movements? Record timing relative to prescription changes and include symptoms that come and go. A brief, accurate description can be more useful than a long list of possible labels.

Sudden muscle spasms affecting the neck, tongue, eyes or throat need prompt medical help. Difficulty swallowing or breathing makes the situation urgent. The MHRA specifically warns that haloperidol-related movement problems in older people can interfere with swallowing and contribute to aspiration risk. Do not wait for a routine review when eating or breathing is affected. [6]

Drowsiness, dizziness or lightheadedness on standing can affect function and increase falls risk. Chlorpromazine also requires attention to dry mouth, urination, sun sensitivity and overheating precautions. Other conventional antipsychotics have their own adverse-effect patterns. Read the individual leaflet rather than assuming that an effect is equally likely with every medicine in the class. [1]

Discuss practical impact: difficulty getting to work, falling when getting up at night, avoiding exercise or struggling to speak because the mouth is dry. Do not drive when impaired. Ask which symptoms require an immediate call and which can be recorded for the scheduled review. A common side effect can still justify reassessing treatment when it interferes with ordinary life.

Monitoring should reflect the actual medicine and medical history. Blood pressure, weight, glucose or HbA1c, lipids, movement symptoms and hormonal concerns belong in antipsychotic care. Heart-rhythm risk is particularly important with some products. The need for an ECG is based on the product information and clinical risk assessment, not simply whether you feel your heartbeat is normal. [5] [6]

Tell the clinician about fainting, palpitations, previous heart conditions and medicines prescribed elsewhere. Discuss sexual symptoms, menstrual changes or breast symptoms without assuming they are unrelated or too private to mention. Ask who orders tests, who receives the results and what action is required if a test is missed.

Acute confusion can arise in a medical illness and needs assessment of the cause. The MHRA advises particular caution with haloperidol in frail older people with delirium: non-drug approaches should be considered first, contraindications checked, and any use kept carefully monitored and short-term. Parkinson’s disease and dementia with Lewy bodies are important contraindications in this context. [6]

A temporary hospital prescription should therefore have a review and stopping plan. Families can ask why it was started, whether the original cause of confusion has improved and who is deciding whether it remains necessary. Do not assume that a medicine given during an acute illness establishes a permanent schizophrenia diagnosis or automatically belongs on the long-term repeat list.

People with psychosis and substance-use difficulties need care for both conditions. NICE recommends coordinated assessment and cautions against assuming that a particular antipsychotic has a proven general advantage for the substance-use problem. Prescribing should follow the psychiatric indication and individual risks. Alcohol and other substances can also affect safety and interpretation of symptoms. [7]

Conventional antipsychotics should not be used as a self-directed detox plan. A medicine that reduces visible agitation does not prove that withdrawal risk has been addressed. Tell the team about alcohol, non-prescribed sedatives, opioids and recent changes in use. Ask which service is responsible for withdrawal assessment and how it will communicate with the psychiatric prescriber.

Fever with severe stiffness, confusion and a fast or unstable heartbeat can indicate neuroleptic malignant syndrome. Collapse, a seizure or major breathing difficulty needs emergency assessment. Jaundice, unusual bleeding or signs of serious infection also require prompt medical advice with relevant medicines. Older adults with dementia-related psychosis have increased mortality risk with antipsychotics; the class should not be treated as a general solution for dementia-related behavior. [1] [2]

Use urgent local help when there is immediate suicidal danger or the person cannot remain safe. Bring the medicine list if readily available, but do not delay care to complete a diary or contact a routine admissions service. Emergency assessment and a planned outpatient medication review serve different purposes.

Withdrawal symptoms can occur after abrupt discontinuation of medicines such as chlorpromazine or perphenazine. Nausea, vomiting, dizziness and shakiness may need assessment, alongside the possibility that the treated condition is returning. NICE recommends gradual antipsychotic withdrawal with relapse monitoring in psychosis care. Do not treat a difficult interruption as proof that the medicine must continue forever or that a faster stop is harmless. [1] [3] [5]

Ask for a written plan stating what changes, which other medicines remain stable and who will review symptoms. Mention earlier stopping attempts and any adverse effects. The withdrawal-or-relapse guide can help frame observations, while the review checklist helps organize priorities.

Bring medicines introduced to manage adverse effects into the same review. Ask what symptom each additional prescription was intended to address, whether that symptom is still present and when continuing need will be reassessed. A past prescription for stiffness should not become an unexplained permanent item on a copied list. Equally, do not remove it yourself without clarifying the plan.

Describe the sequence in ordinary language: which antipsychotic came first, what happened next and which treatment was added. Include benefits as well as new difficulties. Ask the clinician to document the reasoning so a future prescriber does not mistake treatment for an adverse effect for a separate underlying diagnosis. Keep a copy of the agreed list after the review, especially when the hospital and usual pharmacy hold different versions.

Does a small milligram dose mean a mild medicine?

No. Milligram amounts cannot be compared meaningfully across different antipsychotics without a clinical assessment.

Should restlessness simply be accepted?

No. Report distressing or new restlessness, particularly when it follows a treatment change or interferes with normal activity.

Can a hospital prescription be reviewed after discharge?

Yes. Ask for its indication, intended duration and the name of the clinician responsible for deciding what happens next.

1. MedlinePlus: Chlorpromazine.
2. MedlinePlus: Fluphenazine.
3. MedlinePlus: Perphenazine.
4. NICE CG185: Bipolar disorder.
5. NICE CG178: Psychosis and schizophrenia.
6. MHRA: Haloperidol and delirium in older people.
7. NICE CG120: Psychosis and substance misuse.

Explore the haloperidol profile or return to the A-Z directory.